Clinical Trial Update: Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Nordihydroguaiaretic acid for nonmetastatic relapsed prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nordihydroguaiaretic acid (Nordihydroguaiaretic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED